Kusuma Kemindo Sentosa Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kusuma Kemindo Sentosa Tbk. trades at Rp66 (market cap 99B, 12.41M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Kusuma Kemindo Sentosa Tbk. is more actively traded (12.41M versus 96.7K). Which is the better fit depends on your goals.
| KKES | OBAT | |
|---|---|---|
Market Cap | 99B | 167.37B |
Volume | 12.41M | 96.7K |
Lot | 124.07K | 967 |
Turnover | 776.84M | 23.82M |
Average Price | 62.61 | 246.34 |
Value | 776.84M | 23.82M |
Indicative Equilibrium Price | 66 | 248 |
Indicative Equilibrium Volume | 30.86K | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kusuma Kemindo Sentosa Tbk (the Company) was established based on Notarial Deed No. 78 dated November 9, 1990 and amended by Deed No. 64 dated September 16, 1991, both were madebefore Notary James Herman Rahardjo, S.H., Notary in Jakarta.
Read more on KKES →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →